Use when a competitive-intelligence analyst names one indication (e.g. "MASH", "nonalcoholic steatohepatitis", "obesity") and wants the current Phase-3 drug pipeline mapped across every sponsor — running two or more TrialCore searches and unioning them to broaden coverage past any one query's relevance ranking, tagging each program novel-agent vs repurposed-generic, and overlaying the cross-core referencesBiomedCore publication-evidence count as a maturity proxy — emitted as one sorted .xlsx matrix.
